Eli Lilly Files Trademarks for COV-BEAT, COV-BLOCK & COV-BARRIER

Eli Lilly and Company filed three new trademark applications on April 13 for “COV-BEAT,” “COV-BLOCK,” and “COV-BARRIER.”

The applications were all filed on a 1(b) basis, meaning that Eli Lilly was required to sign a declaration stating that it has a bona fide intent to use the trademarks in association with the goods and services listed.

The three filings included “medical and scientific research in the field of coronavirus and infectious diseases” as the services that Eli Lilly intends to use the trademarks in connection with.

While a phrase like “COV-BARRIER” may sound like a treatment for the coronavirus, the company states that the name will only reference research into viruses.

In order to achieve registration, Eli Lilly and Company will need to prove that they have started using the marks in commerce, so we can assume the company has something in the pipeline.

• SHARE THIS ARTICLE ON:

Josh Gerben, Esq.

Josh Gerben, Esq. is a nationally recognized trademark attorney and the founder of Gerben IP. Since launching the firm in 2008, he has overseen the registration of over 10,000 trademarks and handled over 1,500 trademark disputes. Josh's practice focuses on building and defending global trademark portfolios for clients. These clients include entrepreneurs, private equity-backed businesses, athletes, celebrities, and public companies. Frequently quoted by major media outlets like CNBC, CNN, The New York Times, and The Wall Street Journal, Josh is widely regarded as a leading authority in trademark law.